Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners.
Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners.
Following the completion of a hugely successful institutional capital raise — for which the business tapped the market for an extra $317.2 million — shares in payments disruptor AfterPay (ASX:APT) have surged back towards their recent record high. That takes gains for the past 12-months to a whopping 208%. There’s no doubt that things are going well for the business […]
Babe Ruth is one of baseball’s greatest players, but he also led the league in strikeouts. Over his career, he walked back to the dugout about one in every eight times he stepped up to the plate. And yet, he’s remembered as the GOAT. Why? Because when his bat did connect, it often left the park. 714 times, to be exact. […]
Every business, no matter how wonderful, has a few hairs on it. And if you don’t think that’s true, it’s only because you haven’t looked hard enough. But some hairs are, well, hairier than others. It’s not ideal to see the CEO of one of your favourite companies sell shares right before an opportunistic capital raise, but that may be more palatable […]
I recently came across a fascinating, if slightly uncomfortable, piece of research titled Long-Term Shareholder Returns: Evidence from 64,000 Global Stocks (you can read it here). It examines thirty years of market history and reveals an awkward truth: almost all the wealth created by equities comes from a vanishingly small number of companies. Of the 64,000 stocks studied, just 2.4% […]